On the other hand, a case report showed that the tumor in the right parietal lobe with EGFRvIII and EGFR amplification actively progressed on osimertinib while EGFRvIII‐negative left frontal lobe tumor reached a complete response.23, 24. The gene discussed is EGFR; the disease is neoplasm.